Log in

ASX:OVNOventus Medical Stock Price, Forecast & News

-0.01 (-4.00 %)
(As of 05/13/2020)
Today's Range
Now: A$0.24
50-Day Range
MA: A$0.24
52-Week Range
Now: A$0.24
Volume289,932 shs
Average VolumeN/A
Market Capitalization$31.33 million
P/E RatioN/A
Dividend YieldN/A
Oventus Medical Limited, a medical device company, develops and commercializes oral appliances for the treatment of sleep apnoea and snoring in Australia. It offers O2Vent W, a winged-style device to stabilize the jaw; O2Vent T devices that titrate lower jaw forward; O2Vent Mono, a device that advances the lower jaw to a fixed position; and O2Vent nylon and O2Vent ONEPAP appliances. The company was incorporated in 2015 and is headquartered in Indooroopilly, Australia.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.46 out of 5 stars

Industry, Sector and Symbol

Industry Medical Devices
Phone61 7 3831 8866



Sales & Book Value

Annual Sales$368,486.00
Cash FlowA$0.05 per share
Book ValueA$0.08 per share



Market Cap$31.33 million
Next Earnings DateN/A
OptionableNot Optionable

Receive OVN News and Ratings via Email

Sign-up to receive the latest news and ratings for OVN and its competitors with MarketBeat's FREE daily newsletter.

Oventus Medical (ASX:OVN) Frequently Asked Questions

Has Oventus Medical been receiving favorable news coverage?

Headlines about OVN stock have been trending neutral on Saturday, according to InfoTrie Sentiment. The research firm identifies positive and negative news coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Oventus Medical earned a media sentiment score of 0.2 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the next few days. View the latest news about Oventus Medical.

Who are some of Oventus Medical's key competitors?

Who are Oventus Medical's key executives?

Oventus Medical's management team includes the following people:
  • Dr. Christopher Patrick Hart, Co-Founder, MD, CEO & Exec. Director
  • Mr. Neil Anderson, Co-Founder, CTO & Exec. Director (Age 60)
  • Daniel Parry, Chief Financial & Operations Officer
  • Mr. Stephen Denaro BCom, GradDipApp CG, CA, MAICD, Company Sec. & Director
  • Robin Randolph, VP Marketing & Operations of North America

What is Oventus Medical's stock symbol?

Oventus Medical trades on the ASX under the ticker symbol "OVN."

What is Oventus Medical's stock price today?

One share of OVN stock can currently be purchased for approximately A$0.24.

How big of a company is Oventus Medical?

Oventus Medical has a market capitalization of $31.33 million and generates $368,486.00 in revenue each year.

What is Oventus Medical's official website?

The official website for Oventus Medical is www.oventus.com.au.

How can I contact Oventus Medical?

The company can be reached via phone at 61 7 3831 8866.

This page was last updated on 7/11/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.